GlassScriptPhysician profile
Sunil Santhanakrishnan
NPI 1215991617
$11,128.55
in general payments reported to CMS, 2019-2025
47 companies · $1,268 in 2025
The $1,268 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,001 · 2020: $974 · 2021: $1,650 · 2022: $1,756 · 2023: $2,027 · 2024: $1,452 · 2025: $1,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,672 · Education: $75.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,671.79 |
| Education | $75.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,172.53 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $987.37 | 2019-2024 | Trelegy Ellipta, Nucala |
| Actelion Pharmaceuticals US, INC. | $930.55 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Electromed, INC. | $874.45 | 2019-2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $851.20 | 2019-2025 | Ofev |
| United Therapeutics Corporation | $793.80 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Imvaria INC. | $434.33 | 2024 | |
| Insmed, INC. | $413.38 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $400.04 | 2019-2024 | Dupixent |
| Abiomed | $366.68 | 2023-2025 | Impella |
| Genentech USA, INC. | $364.29 | 2019-2023 | Xolair |
| Genzyme Corporation | $357.19 | 2019-2024 | |
| Mylan Specialty L.P. | $275.70 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $254.11 | 2020-2024 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $233.87 | 2019-2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $205.03 | 2019-2023 | |
| Baxter Healthcare | $186.58 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Advanced Respiratory, INC | $173.13 | 2019-2021 | |
| Amgen INC. | $160.46 | 2022-2025 | Tezspire |
| Sandoz INC. | $138.42 | 2019-2022 | |
| La Jolla Pharmaceutical Company | $137.45 | 2023 | Giapreza |
| Penumbra, INC. | $129.87 | 2019 | |
| Sunovion Pharmaceuticals INC. | $129.68 | 2019-2021 | |
| Abbvie INC. | $128.79 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $121.27 | 2019-2024 | |
| Grifols Shared Services North America, INC. | $120.18 | 2025 | Prolastin-C Liquid |
| Intuitive Surgical, INC. | $90.31 | 2024 | |
| Verona Pharma, INC. | $84.69 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $63.36 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $54.29 | 2021-2022 | |
| Viatris Specialty LLC | $51.64 | 2025 | Yupelri |
| Pulmonx Corporation | $42.47 | 2019-2021 | |
| Grifols USA, LLC | $41.88 | 2019-2020 | |
| Shire North American Group INC | $41.03 | 2019 | |
| Getinge USA Sales, LLC | $37.64 | 2022 | |
| Vapotherm INC | $36.56 | 2022 | |
| Gilead Sciences, INC. | $32.11 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $31.47 | 2023-2024 | Uptravi, Opsumit |
| Paratek Pharmaceuticals, INC. | $29.28 | 2021 | |
| Atricure, INC. | $27.27 | 2023 | |
| Allergan, INC. | $23.21 | 2019 | |
| Jazz Pharmaceuticals INC. | $22.12 | 2019 | |
| Phadia US INC. | $17.65 | 2025 | Immunocap |
| Abbott Laboratories | $17.37 | 2022 | |
| Inogen, INC. | $15.80 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Teva Pharmaceuticals USA, INC. | $14.21 | 2022 | |
| Inspire Medical Systems, INC. | $13.84 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Santhanakrishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.